ICDM 2025

Research group on beta cell biology and islet transplantation Beta cell homeostasis and metabolic tissue identity: molecular mechanisms and therapeutic implications Chair(s): Kyuchang Won, Hail Kim
Thursday 25 September, 15:00~16:20
Room 1
(Vista 1+2, B2F)

RG01-L1 Rohit KulkarniJoslin Diabetes Center, USA: Mechanisms underlying β-cell compensation to prevent progression of diabetes

RG01-L2 Feyza EnginUniversity of Wisconsin-Madison, USA: ER stress enforces adaptive β-cell plasticity in type 1 diabetes

RG01-L3 Young Min ChoSeoul National University, Korea: Targeting β-cell senescence through mitochondrial-derived peptides

Research group on diabetic nephropathy Current challenges and emerging perspectives in diabetic kidney disease research Chair(s): Nan Hee Kim, Dong-Lim Kim
Thursday 25 September, 15:00~16:20
Room 2
(Vista 3, B2F)

Diabetic kidney disease (DKD) is the leading cause of end-stage kidney disease. It is a multifactorial condition, and research has shown that youth-onset type 2 diabetes (T2DM) carries a higher risk of progressive DKD compared to adult-onset T2DM. While several medications are available to help prevent DKD, significant unmet needs remain in this area. This session will discuss the characteristics of DKD in the Korean population and among youth-onset T2DM, as well as key considerations for DKD research to address these unmet needs.

RG02-L1 Jung A KimKorea University, Korea: Trajetories of DKD progression in Korean cohort

RG02-L2 Petter BjornstadUW Medicine Diabetes Institute, USA: Diabetic kidney disease in young people: how it differs from adult case

RG02-L3 Jennifer B. GreenDuke University, USA: Challenges and opportunities in chronic kidney disease trials

Research group on genetics Diabetes genomics, metabolomics, and big data platforms Chair(s): Sung-Hoon Kim, Suk Kyeong Kim
Thursday 25 September, 15:00~16:20
Room 3
(Walker hall 1, 1F)

This session spotlights the integration of genomics, metabolomics, and national big data platforms in advancing diabetes research. Presentations will cover key resources like the Type 2 Diabetes Knowledge Portal, Korea’s national bio big data project, polygenic risk scores, and metabolomic signatures. Together, these initiatives demonstrate the power of large-scale data in uncovering disease mechanisms and enabling precision prevention and treatment strategies for diabetes.

RG03-L1 Noel BurttBroad Institute of Harvard and MIT, USA: Type 2 diabetes knowledge portal: data & tools you need for diabetes research

RG03-L2 Jongbum JeonKOBIC, Korea: Challenges and opportunities of the national genome projects in Korea

RG03-L3 Alisa ManningMassachusetts General Hospital, USA: Polygenic risk score of diabetes

RG03-L4 Hyunbeom LeeKIST, Korea: Metabolomics-based insights into diabetic kidney disease and drug response from a large-scale clinical cohort

Research group on energy metabolism Metabolic organ experimental modelling Chair(s): Sunghee Choi, Obin Kwon
Thursday 25 September, 16:30~17:50
Room 3
(Walker hall 1, 1F)

This session will highlight cutting-edge technologies in understanding of metabolic diseases, including single-cell RNA sequencing, organoid models, and organ-on-chip systems. Topics will include understanding adipose tissue cellular heterogeneity, exploring mechanisms of energy metabolism and therapeutic target discovery in pancreatic cancer using organoid models, and the application of organ-on-chip technology in metabolic disease modeling.

RG05-L1 Lucas MassierHelmholtz Munich, Germany: Adipose tissue microarchitecture and its relevance for metabolic disorders

RG05-L2 Noo Li JeonSeoul National University, Department of Mechanical Engineering, Korea: Vascularized microphysiological systems: high-throughput micro-organs on a plate

RG05-L3 Sungsoon FangYonsei University, Department of Biomedical Science, Korea: Proteostasis & ERR alpha-mediated mitochondrial activity in Pancreatic cancer

Research group on diabetic neuropathy Diabetic neuropathy: bridging the gaps in research and practice Chair(s): Ie Byung Park, Chong Hwa Kim
Thursday 25 September, 15:00~16:20
Room 5
(Art Hall, 4F)

This session on Diabetic Neuropathy: Bridging the Gaps in Research and Practice highlights emerging insights into novel biomarkers and neuroinflammation (Lecture 1), explores key molecular mechanisms in cardiovascular autonomic neuropathy (Lecture 2), and presents advanced integrative management strategies for peripheral neuropathy (Lecture 3). these lectures bridge research and clinical practice, promising enhanced diagnostic precision, targeted interventions, and comprehensive patient care strategies to improve neuropathy outcomes and quality of life.

RG04-L1 Jeehee YoonChonnam National University, Korea: Novel biomarkers and neuroinflammation in diabetic neuropathy: from bench to bedside

RG04-L2 Jae-Seung YunThe Catholic University of Korea, Korea: Molecular mechanisms underpinning of cardiovascular autonomic neuropathy: translating research to practice

RG04-L3 Bin LuFudan University, China: Integrative and cutting-edge approaches to diabetic peripheral neuropathy management

Panel discussion

RG04-P1
Seon Mee KangSoonchunhyang University, Korea
RG04-P2
Eun Sook KimThe Catholic University of Korea, Korea
RG04-P3
Chong Hwa Kim Sejong General Hospital, Korea

Research group on CGM and AID 1 Hot topics in CGM for intensive insulin therapy Chair(s): Jae Hyeon Kim, Jae Hyuk Lee
Thursday 25 September, 16:30~17:50
Room 5
(Art Hall, 4F)

This session will highlight recent advances and key challenges in continuous glucose monitoring (CGM) for intensive insulin therapy. Experts will discuss nationwide education initiatives including RCT data on CGM-focused education for T1D, the role of current and next generation smart insulin pens, and explore whether time in tight range is superior to time in range for prediction of A1C targets and albuminuria. These insights will help update clinical practice with the latest technological advances.

RG06-L1 Jee Hee YooChung-Ang University, Korea: A nationwide education program in Korea for T1D: focused on CGM

RG06-L2 So Yoon KwonDaegu Catholic University, Korea: Smart insulin pen in 2025

RG06-L3 Ji Yoon KimSungkyunkwan University, Korea: Time in tight range in insulin users: better than time in range?

Panel discussion

RG06-P1
Sun-Joon MoonSungkyunkwan University, Korea
RG06-P2
Soo Kyoung KimGyeongsang National University, Korea
RG06-P3
Sang-Man JinSungkyunkwan University, Korea

Research group on development of new drug and technology on metabolic disease Emerging vascular and metabolic modulators in tissue remodeling and fibrosis Chair(s): Choon Hee Chung, Seung Soon Im
Saturday 27 September, 14:40~16:00
Room 1
(Vista 1+2, B2F)

This session explores emerging mechanisms linking vascular signaling, metabolism, and tissue remodeling in chronic diseases. Presentations will highlight recent advances in how cellular interactions and regulatory pathways influence fibrosis, muscle health, and systemic metabolic balance. By integrating diverse models and approaches, the session aims to offer insights into novel therapeutic strategies targeting complex conditions involving the liver, vasculature, and musculoskeletal system.

RG12-L1 Yong Soo KimNovatis Pharma AG, Korea: MASH drug pipelines: from discovery to clinical translation

RG12-L2 Joonghoon ParkSeoul National University, Graduate School of International Agricultural Technology, Korea: Prokineticin receptor 1 (PROKR1/GPR73) agonist to treat sarcopenia through oxidative muscle fiber enhancement

RG12-L3 You Mie LeeKyungpook National University, Department of Pharmacology, Korea: Maintaining LSEC gatekeeping function by RUNX3 is crucial for prevention of liver fibrosis

Panel discussion

RG12-P1
Eun Yeong HaKeimyung University, Korea
RG12-P2
Du-Hyong ChoYeungnam University, Department of Pharmacology, Korea
RG12-P3
Eun-Hee ChoKangwon National University, Korea

Research group on diabetes in old age Highlights of position statement on diabetes treatment for old age in Korea Chair(s): Dong-Hyeok Cho, Young Jung Cho
Saturday 27 September, 14:40~16:00
Room 2
(Vista 3, B2F)

RG08-L1 Sung Hoon YuHanyang University, Korea: Assessment and frailty

RG08-L2 Eun RohSeoul National University, Korea: Glycemic target and pharmacotherapy

RG08-L3 Yong-ho LeeYonsei University, Korea: Long term care and end of life care

Panel discussion

RG08-P1
Kyung-Soo KimCHA University, Korea
RG08-P2
Young Na The Catholic University of Korea, Yeouido ST. Mary’s Hospital, Korea
RG08-P3
Junghyun NohInje University, Korea
RG08-P4
Jeong Hyun LimSeoul National University Hospital, Department of Nutrition, Korea
RG08-P5
Sangmo HongHanyang University, Korea

Research group on diabetic vascular disease Unveiling hidden culprits in diabetic atherosclerosis Chair(s): In-Kyung Jeong, Hunsang Lee
Saturday 27 September, 14:40~16:00
Room 3
(Walker hall 1, 1F)

Recent research has revealed that cellular players such as monocytes, macrophages, mitochondria, and bone marrow stem cells are key contributors to diabetic atherosclerosis. These components offer novel mechanistic insights into the pathogenesis of diabetic vascular disease. The Research Group on Diabetic Vascular Disease presents a focused session featuring three leading experts in the field. Each lecture will highlight emerging evidence on cellular contributors and their roles in vascular inflammation and remodeling. Together, the session will explore the translational implications of these findings for future therapeutic strategies.

RG09-L1 Yong Joo AhnPOSTECH, Korea: The role of monocytes and macrophages in atherosclerosis

RG09-L2 Andreas ZirlikMedical University of Graz, Austria: Immunologic patterns driving and predicting risk in diabetic atherosclerosis

RG09-L3 Kae Won ChoSoonchunhyang University, Korea: Obesity-educated bone marrow stem cells: a hidden driver of atherosclerosis

Panel discussion

RG09-P1
You-Cheol HwangKyung Hee University, Korea
RG09-P2
Chang Hee JungUniversity of Ulsan, Korea
RG09-P3
Mihye SeoSoonchunhyang University, Korea

Research group on digital health (K) Digital health and artificial intelligence: current trends and future directions in chronic disease research Chair(s): Tae Sun Park, Hye Jin Yoo
Saturday 27 September, 14:40~16:00
Room 4
(Walker hall 2, 1F)

This session explores the latest technologies and research methodologies in digital health, emphasizing the role of artificial intelligence in chronic disease management and behavioral analysis. Key topics include modeling techniques for AI research in chronic diseases, AI applications in decoding behavior, and advanced data platform technologies supporting multi-institutional medical big data research. Additionally, the session provides insights into the activities and future plans of the Korean Diabetes Association Digital Health Research Group, aiming to foster practical implementations in clinical settings.

RG10-L1 Seogsong JeongKorea University College of Medicine, Korea: Modeling research techniques for artificial intelligence research on chronic diseases and their development direction
(만성질환 인공지능 연구를 위한 모델링 연구기법과 그 발전 방향)

RG10-L2 Jee Hang LeeSangmyung University, College of Biohealth Convergence and Innovation, Korea: Artificial intelligence that unlocks the secrets of behavior
(행동의 비밀을 푸는 인공지능)

RG10-L3 Hancheol JekalKakaoHealthcare Corp., Korea: Introduction to the latest data platform technology for multi-institutional medical big data research
(다기관 의료 빅데이터 연구를 위한 최신 데이터 플랫폼 기술의 소개)

RG10-L4 Sang Youl RheeKyung Hee University, Korea: Introduction to the Korean diabetes association digital health research group
(대한당뇨병학회 디지털헬스연구회 소개)

Research group on CGM and AID 2 Maximizing CGM and AI in diabetes care: from personalized timing to automated systems Chair(s): Soon Hee Lee, Keeho Song
Saturday 27 September, 14:40~16:00
Room 5
(Art Hall, 4F)

This session focuses on maximizing the potential of continuous glucose monitoring (CGM) and automated insulin delivery (AID) system. Presentations will cover personalized strategies such as optimal exercise timing, improving AID system performance, and the feasibility of fully closed-loop approaches. Together, these talks highlight the integration of technology and individualization to enhance clinical outcomes.

RG11-L1 Yeoree YangThe Catholic University of Korea, Korea: Timing matters: optimizing exercise for type 2 diabetes management

RG11-L2 Revital NimriTel-Aviv University, Israel: Strategies for optimal performance in the use of automated insulin delivery systems

RG11-L3 Sun-Joon MoonSungkyunkwan University, Korea: Exploring the feasibility of fully closed-loop systems in type 2 diabetes treatment

Panel discussion

RG11-P1
Young Sang LyuChosun University, Korea
RG11-P2
Jun Hwa HongEulji University, Korea
RG11-P3
Da Young LeeKorea University, Korea

구분		사전등록 (~2025년 8월 20일까지)		현장등록 (2025년 9월 25일 ~ 27일)
구분		KDA회원	비회원	KDA회원	비회원
25~27일 등록	전문의(개원의, 교수, 봉직의, 전임의 포함)	KRW 280,000	KRW 350,000	KRW 370,000	KRW 450,000
25~27일 등록	전공의, 간호사, 영양사, 사회복지사, 약사, 연구원, 운동처방사, 관련분야 교수 및 기타 (군의관 및 공중보건의 포함)	KRW 180,000	KRW 230,000	KRW 250,000	KRW 270,000
One-day 등록	전문의(개원의, 교수, 봉직의, 전임의 포함)	KRW 170,000	KRW 210,000	KRW 220,000	KRW 270,000
One-day 등록	전공의, 간호사, 영양사, 사회복지사, 약사, 연구원, 운동처방사, 관련분야 교수 및 기타 (군의관 및 공중보건의 포함)	KRW 110,000	KRW 140,000	KRW 150,000	KRW 160,000
저녁 식사	전체	KRW 55,000

Program details

평점안내 (For Korean)